Thomas Wei

Thomas Wei

Chief Tech/Sci/R&D Officer at AURINIA PHARMACEUTICALS INC.
50 year
Finance
Consumer Services
Health Technology

Profile

Mr. Thomas Wei is a Chief Scientific Officer at Tang Capital Acquisition Corp., a Chief Scientific Officer at Aurinia Pharmaceuticals, Inc. and a Managing Director at Tang Capital Management LLC.
Mr. Wei was previously employed as a Chief Scientific Officer by Odonate Therapeutics, Inc., an Equity Analyst by Jefferies LLC, a Managing Director & Principal by U.S.
Bancorp Piper Jaffray Ventures, a Research Associate by Deutsche Bank Securities, Inc., an Analyst by Adams Harkness & Hill Investment Banking, and a Managing Director by Piper Jaffray & Co. (Broker).
He received his undergraduate degree from Harvard University and an MBA from the University of Oxford.

Thomas Wei active positions

CompaniesPositionStart
AURINIA PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer 20/03/2026
Portfolio Manager-Equities 31/12/2014

Former positions of Thomas Wei

CompaniesPositionEnd
ODONATE, INC. Chief Tech/Sci/R&D Officer 30/11/2021
Corporate Officer/Principal 29/09/2009
Analyst-Equity 14/08/2009
Analyst-Equity -
Corporate Officer/Principal 29/04/2000
See the detail of Thomas Wei's experience

Training of Thomas Wei

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Finance

Finance

Finance

Finance

Consumer Services

Consumer Services

Finance

Finance

Health Technology

Health Technology